| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas J. Errico | Director | 2026-09-14 | 5,000 | $9.82 | $49.08kBuy |
| Michael Fox | CEO;COO;Pres | 2026-09-11 | 5,000 | $9.80 | $49.01kBuy |
| Michael Fox | CEO;COO;Pres | 2026-09-11 | 5,000 | $9.80 | $49.01kBuy |
| Michael Fox | CEO;COO;Pres | 2026-09-11 | 5,000 | $9.80 | $49.01kBuy |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-25 | 3,000 | $9.36 | $28.08kSell |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-25 | 3,000 | $4.50 | $13.50kBuy |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-24 | 5,000 | $9.88 | $49.40kSell |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-24 | 5,000 | $4.50 | $22.50kBuy |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-21 | 12,000 | $10.22 | $122.64kSell |
| Joshua S. Lev | CFO;Pres;Interim | 2026-08-21 | 12,000 | $4.50 | $54.00kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph P. Errico | 42.83% | 3,861,942 | $32.40M | Insider |
| Merck Global Health Innovation Fund LLC | 37.11% | 3,346,032 | $28.07M | Insider |
| James L. L. Tullis | 22.34% | 2,014,110 | $16.90M | Insider |
| Thomas J. Errico | 11.86% | 1,068,994 | $8.97M | Insider |
| Core Ventures II LLC | 7.17% | 646,342 | $5.42M | Insider |
| Peter S. Staats | 5.28% | 476,419 | $4.00M | Insider |
| Charles Steve Theofilos | 5.13% | 462,758 | $3.88M | Insider |
| Francis R. Amato | 4.09% | 368,355 | $3.09M | Insider |
| Daniel S. Goldberger | 2.35% | 211,471 | $1.77M | Insider |
| Joshua S. Lev | 1.55% | 139,889 | $1.17M | Insider |